Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 7 studies | 30% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 35% ± 8% | |
brush cell | 4 studies | 65% ± 17% |
Insufficient scRNA-seq data for expression of IL17RB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1532.68 | 2640 / 2642 | 99% | 31.42 | 698 / 705 |
liver | 100% | 1923.60 | 226 / 226 | 97% | 47.84 | 392 / 406 |
pancreas | 100% | 779.78 | 328 / 328 | 88% | 13.26 | 156 / 178 |
kidney | 100% | 6636.49 | 89 / 89 | 84% | 45.27 | 759 / 901 |
prostate | 90% | 584.34 | 221 / 245 | 92% | 10.62 | 460 / 502 |
stomach | 83% | 403.80 | 299 / 359 | 95% | 25.80 | 271 / 286 |
intestine | 80% | 682.33 | 773 / 966 | 95% | 26.08 | 501 / 527 |
breast | 67% | 1251.47 | 306 / 459 | 93% | 24.67 | 1035 / 1118 |
uterus | 83% | 865.11 | 141 / 170 | 65% | 11.73 | 297 / 459 |
thymus | 94% | 352.99 | 614 / 653 | 47% | 3.50 | 287 / 605 |
lung | 89% | 414.73 | 515 / 578 | 52% | 8.06 | 600 / 1155 |
ovary | 86% | 220.03 | 154 / 180 | 49% | 5.70 | 212 / 430 |
esophagus | 23% | 48.08 | 336 / 1445 | 56% | 16.04 | 102 / 183 |
tonsil | 0% | 0 | 0 / 0 | 76% | 13.41 | 34 / 45 |
bladder | 19% | 34.76 | 4 / 21 | 52% | 10.57 | 260 / 504 |
adrenal gland | 57% | 153.18 | 148 / 258 | 6% | 0.35 | 13 / 230 |
lymph node | 0% | 0 | 0 / 0 | 62% | 32.51 | 18 / 29 |
skin | 27% | 62.54 | 496 / 1809 | 23% | 1.79 | 110 / 472 |
muscle | 38% | 82.10 | 302 / 803 | 0% | 0 | 0 / 0 |
heart | 33% | 83.67 | 282 / 861 | 0% | 0 | 0 / 0 |
spleen | 24% | 47.07 | 57 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 421.55 | 179 / 929 | 0% | 0 | 0 / 0 |
adipose | 11% | 22.14 | 136 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 11% | 22.88 | 148 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0001558 | Biological process | regulation of cell growth |
GO_0006952 | Biological process | defense response |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030368 | Molecular function | interleukin-17 receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0004896 | Molecular function | cytokine receptor activity |
Gene name | IL17RB |
Protein name | Interleukin 17 receptor B Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor) |
Synonyms | CRL4 UNQ2501/PRO19612 EVI27 IL17BR |
Description | FUNCTION: Receptor for the pro-inflammatory cytokines IL17B and IL17E. May play a role in controlling the growth and/or differentiation of hematopoietic cells. . |
Accessions | Q9NRM6 ENST00000494338.1 C9IZN0 ENST00000288167.8 [Q9NRM6-1] |